Intelligence Hub
Market analytics and operational performance indicators
Insider Trading - December 22, 2025
Director Saintil sold 5,000 shares ($325K) via 10b5-1 plan.
Brief
Merline Saintil, Director at Rocket Lab USA, sold 5,000 shares of common stock at $65 per share on 12/19/2025. The sale was automatic under a Rule 10b5-1 trading plan adopted 9/17/2025. Neutral signal due to pre-scheduled nature.
Detailed Brief
Merline Saintil, a Director, reported selling 5,000 shares of RKLB common stock on December 19, 2025, at $65 per share (total value $325,000), leaving her with 388,529 shares held directly. The transaction was executed automatically pursuant to a Rule 10b5-1 trading plan adopted on September 17, 2025, as indicated by the checkbox and footnote. No derivative transactions in Table II. This appears to be a routine planned sale with no indication of discretionary timing or distress; no historical pattern provided in filing, but 10b5-1 plans mitigate concerns over insider timing.
Key Telemetry
- • Sold 5,000 shares (~1.3% of post-sale direct holdings of 388,529 shares)
- • Automatic sale under 10b5-1 plan adopted Sep 17, 2025 (first referenced here)
- • At $65/share; no price context like 52-week extremes given
- • Neutral; standard scheduled disposition, no cluster or large sale
Impact Vector
This pre-planned 10b5-1 sale signals neutral insider confidence, as it reflects a routine, non-discretionary divestiture rather than opportunistic selling. No evidence of reduced commitment to RKLB.